pharmacology journal
TRANSCRIPT
PHARMACOLOGY JOURNAL
Allergy And Anaphylaxis
Analgesics
Anaesthetic Agents
Anti-Infectives
Cardiovascular Drugs
Blood And Electrolytes
Dermatological Drugs
Ear, Nose and Throat Drugs
Endocrine Drugs
Eye Drugs
Gastrointestinal Drugs
Genitourinary Drugs
Immunomodulators and Antineoplastics
Musculoskeletal Drugs
Neurological Drugs
Obstetric and Gynaecological Drugs
Psychotropic Drugs
Respiratory Drugs
1. Acyclovir
2. Adenosine
3. Adrenaline
4. Amiodarone
5. Amitriptyline
6. Amphetamine/MDMA
7. Aspirin/salicylates
8. Atropine
9. Azathioprine
10. Calcium chloride
11. Carbamazepine
12. Ceftriaxone
13. Charcoal
14. Chloramphenicol
15. Chloroquine
16. Chlorpromazine
17. Ciprofloxacin
18. Clonidine
19. Cocaine
20. Codeine
21. Colchicine
22. Cyclophosphamide
23. Diazepam
24. Digoxin
25. Diltiazem
26. Dobutamine
27. Dopamine
28. Enalapril
29. Ethanol
30. Fentanyl
31. Flumazenil
32. Fluoxetine
33. Frusemide
34. Gentamicin
35. Gliclizide
36. Glucagon
37. Glyceryl trinitrate
38. Haloperidol
39. Halothane
40. Heparin
41. Hydralazine
42. Ibuprofen
43. Insulin
44. Iron
45. Isoniazid
46. Ketamine
47. Levo-dopa
48. Lignocaine
49. Lithium
50. Magnesium
51. Metformin
52. Methotrexate
53. Metoclopramide
54. Metronidazole
55. Midazolam
56. Morphine
57. N-Acetylcysteine
58. Naloxone
59. Neostigmine
60. Nifedipine
61. Nitrous oxide
62. Octreotide
63. Omeprazole
64. Ondansetron
65. Oxygen
66. Oxytocin
67. Paracetamol
68. Penicillin
69. Phenobarbitone
70. Phenytoin
71. Potassium chloride
72. Prazosin
73. Prednisone
74. Promethazine
75. Propranolol
76. Propofol
77. Propylthiouracil (PTU)
78. Quinine
79. Ranitidine
80. Rifampicin
81. Salbutamol
82. Simvastatin
83. Sodium bicarbonate
84. Sotalol
85. Streptokinase
86. Sumatriptan
87. Suxamethonium
88. Tetracycline
89. Theophylline
90. Thiopentone
91. Thyroxine
92. t-PA
93. Valproic acid
94. Vancomycin
95. Vasopressin
96. Vecuronium
97. Venlafaxine
98. Verapamil
99. Warfarin
100. Zidovudine
ALLERGY AND ANAPHYLAXIS
Anaphylaxis
Most anaphylactic reactions are mediated by IgE, they ae typically precipitated by insect stings, foods, drugs, blood products, latex, food chemicals or additives
Symptoms of Anaphylaxis inc.
Urticaria
Angioedema
Respiratory distress – fatalities most often result from respiratory obstruction due to upper airway oedema (tongue and laryngeal) or bronchospasm with small airway obstruction
Vomiting
Diarrhoea
Hypotension – which may result in a stroke, MI, arrythmias or death
Rationale for Drug Use
Prevention of serious complications or death
Cardiorespiratory support
Symptom releif
Management of Anaphylaxis
Sympathomimetics – Adrenaline
IV fluids – required to expand intravascular volume and restore BP in combination with adrenaline
Bronchodilators – to help relieve bronchospasm
Glucagon – may help persistent hypotension in patients on beta-blockers
Corticosteroids – used to reduce duration of reaction and prevent relapse
Allergic Reactions
Moderate allergic reactions inc.
Seasonal and perennial rhinitis
Allergic conjunctivitis
Less severe reactions to insect bites and stings
Urticaria
Angioedema
Rationale for treatment is symptom relief
Identify allergen if possible – RAST (specific IgE), skin-prick testing
Avoid allergen
Management of Allergic Reactions - Antihistamines (H1 Antagonists)
Sedating Antihistamines
Cyproheptadine
Dexchlorpheniramine
Pheniramine
Promethazine Hydrochloride
Trimeprazine
Less-Sedating Antihistamines
Cetirizine
Desloratadine
Fexofenadine
Levocetirizine
Loratadine
Drug Name Adrenaline (Epinephrine)
Drug Class Sympathomimetics (Anaphylaxis)
Mode Of Action
Non-selective adrenergic agonist
- Positive inotrope and chronotrope (beta1 receptors)
- Vasodilator at low dose (beta2 receptors)
- Vasoconstrictor at high dose (alpha receptors)
- Bronchial smooth muscle relaxant (beta2 receptors)
- Stabilises mast cells
Indications
Severe allergic reactions inc. anaphylactic shock, life-threatening angioedema
Bronchospasm and croup
Cardiac arrest
Inotropic support in acute heart failure and cardiogenic shock, acute exacerbation of chronic heart failure, septic shock, positive end expiratory pressure ventilation
Adjunct in local anaesthesia
Precautions
**There are NO contraindications in severe life-threatening allergic reactions.
- IHD and CVD – increased sensitivity to sympathomimetic effects inc. arrhthmias, angina, myocardial ischaemia
Contraindicated in:
- Phaeochromocytoma
- Tachyarrhythmias
Adverse Effects
Common
Anxiety, fear
Headache
Palpitations
Tachycardia
Restlessness
Tremor
Dizziness
Dyspnoea
Weakness
Sweating
Pallor
Hyperglycaemia
Infrequent
Excessive increase in BP, ventricular arrhythmias, pulmonary oedema, angina, peripheral ischaemia, necrosis (at infusion site)
Rare
Allergic reaction
Overdose, or Rapid IV Administration
Arrhythmias, severe hypertension, cerebral haemorrhage, pulmonary oedema
Dosage
Adult - Anaphylaxis
IM 10micrograms/kg up to 500micrograms (EpiPen 300micrograms, 3mL)
IV 5micrograms/kg
Adult – Cardiac Arrest
IV 0.5-1mg (Adrenaline 1:10,000 is 0.1mg/mL, 10mL)
IV Infusion 1-4micrograms/minute
Drug Name Promethazine Hydrochloride
Drug Class Antihistamine
Mode Of Action
Antihistamines are divided into 2 groups: older sedating drugs and newer less sedating drugs.
Sedating antihistamines (like promethazine) antagonise the action of histamine at H1 receptors, reducing histamine-related vasodilation and increased capillary permeability. They also have anticholinergic activity, some alpha-blocking activity and some antiserotonin activity.
Less sedating antihistamines selectively anatagonise the action of histamine at H1 receptors – histamine release causes vasodilation and increases capillary permeability.
Indications
Allergic upper respiratory conditions, inc. rhinitis
Allergic skin conditions, inc. urticaria, contact dermatitis
Pruritis
Nausea and vomiting, inc. motion sickness
Sedation
Precautions
Contraindicated in:
- Closed angle glaucoma, increased intraocular pressure, bladder neck obstruction, hyperthyroidism – may be worsened by the anticholinergic effects of antihistamines
- Epilepsy – promethazine lowers the seizure threshold
Adverse Effects
Common
Sedation
Dizziness
Tinnitus
Blurred vision
Euphoria
Incoordination
Anxiety
Insomnia
Tremor
Nausea and vomiting
Constipation and diarrhoea
Epigastric discomfort
Dry mouth
Cough
Infrequent
Urinary retention, palpitations, hypotension, headache, hallucinations, psychosis, thrombophlebitis
Rare
Leucopenia, agranulocytosis, haemolytic anaemia, allergic reactions, arrhythmias, dyskinesia, paraesthesia, paralysis, hepatitis, seizures
Dosage
Adult (do NOT give SC, avoid IV because of risk of thrombophlebitis)
Allergy Oral 25-75mg once daily, or 10-25mg 2-3 times daily (Phenergan – 10mg, 25mg tab)
IM 25-50mg single dose
ANALGESICS
Analgesics are used to treat pain, which is clinically classified as:
Nociceptive Pain due to activation of normal pain fibres in response to a noxious stimulus (ie. injury, disease, inflammation); it may be somatic (involving superficial structures ie. skin, muscle) or visceral (involving deeper organs ie. liver, pancreas)
Neuropathic Pain due to injury, disease or dysfunction affecting the peripheral nervous system (ie. post-herpatic neuralgia, diabetic neuropathy) or central nervous system (ie. spinal cord injury, post-stroke)
Types of Analgesics
Non-Steroidal Anti-Inflammatory Drugs ( NSAIDs )
Non-Selective NSAIDs (COX-1 and COX-2 Inhibitors)
Aspirin
Diclofenac
Ibuprofen
Indomethacin
Ketoprofen
Ketorolac
Mefanamic Acid
Naproxen
Piroxicam
Sulindac
Tiaprofenic Acid
Selective NSAIDs (COX-2 Inhibitors)
Celecoxib
Meloxicam
Parecoxib
Other Non-Opioid Analgesics
Paracetamol
Opioid Analgesics
Buprenorphine
Dextropropoxyphene
Hydromorphine
Morphine
Pethidine
Codeine
Fentanyl
Methadone
Oxycodone
Tramadol
The choice of analgesic depends on the type of pain:
Drug Nociceptive Pain Neuropathic Pain
ParacetamolEffective (negligible anti-inflammatory effects)
Less effective
NSAIDs Effective (useful anti-inflammatory effects) Less effective
Opioids Effective May be effective
TCAs, Parenteral local anaesthetics, antiepileptics, clonidine
Rarely used May be effective
Route of Administration
Oral, IV, IM, SC, PCA, Transdermal, Inhaled (mainly for NO), Epidural, Intrathecal, Regional Nerve Blockade
Drug Name Aspirin (Acetylsalicylic Acid)
Drug Class Analgesic, Antipyretic, Anti-Inflammatory, Anti-Platelet
Mode Of Action
Non-selective NSAID, preventing the synthesis of prostaglandins by non-competitively inhibiting both forms of cyclo-oxygenase (COX), COX-1 and COX-2. It irreversibly inhibits COX-1 and modifies the enzymatic activity of COX-2.
COX is required for prostaglandin (pro-inflammatory) and thromboxane (promote clotting, vasoconstrictor) synthesis. Aspirin acts as an acetylating agent where an acetyl group is covalently attached to a serine residue in the active site of the COX enzyme. Hence the duration of effect depends on the rate of enzyme resynthesis.
Aspirin irreversibly blocks the formation of thromboxane A2 in platelets producing an inhibitory effect on platelet aggregation.
Indications
Inhibit platelet aggregation
Mild-Moderate pain
Fever
Rheumatic fever, Rheumatoid arthritis, Kawasaki’s disease
Precautions
Contraindicated in:
- Allergy to aspirin or other NSAIDs
- Haemophilia
- Heart failure, uncontrolled hypertension – may be exacerbated by sodium and fluid retention caused by aspirin-induced reduction in GFR and renal blood flow
- Peptic ulcer disease- increased risk of GI ulceration
- Renal and hepatic impairment – increased risk of bleeding
Adverse Effects
Common
Nausea
Dyspepsia
Vomiting
GI Ulceration or bleeding
Asymptomatic blood loss
Increased bleeding time
Headache
Dizziness
Rare
Skin reactions, iron-deficiency anaemia, renal impairment, oesophageal ulceration, major haemorrhage
Dosage
Adult 300-900mg every 4-6hrs when necessary (available in 300mg white tablets)
Drug Name Paracetamol (Acetaminophen)
Drug Class Analgesic; Antipyretic
Mode Of Action (Not fully determined)
Analgesic effec may be due to inhibition of prostaglandin synthesis centrally, and may be involved in ther mechanisms which peripherally block pain impulses.
Antipyretic effect probably due to reduced prodution of prostaglandins in the hypothalamus
Indications
Mild to moderate pain
Fever
Precautions
- Sodium restriction – soluble paracetamol products may contain large amounts of sodium
- Phenylketonuria – soluble paracetamol products may contain aspartame
Contraindicated in:
- Chronic liver disease – pts may be at increased risk of liver damage
(safe to use in pregnancy and breastfeeding)
Adverse Effects
Common
Increased transaminases (Hepatotoxicity, which can occur following paracetamol overdose)
Rare
Utricarial or erythematous rash, drug fever, mucosal lesions, hypersensitivity reactions, neutropenia, thrombocytopenia, pancytopenia, acute hepatitis, hypotension
Dosage
Adult
Oral 0.5-1g every 4-6hrs (max 4g daily)
Oral Controlled Release 2 tablets (665mg per tablet) every 6-8hrs swallowed whole (max 6 tablets daily)
IV Infusion 1g (100mL) every 4-6hrs (max 4g daily) – IV infusion given over 15min
Combination Doses
Paracetamol Codeine Combination (Panamax, Prodeine, Panadeine Forte) 1-2tablets (paracetamol 500mg, codeine 8, 15, 30mg) every 4-6hrs if needed (max 8 tablets daily)
Paracetamol Metoclopramide Combination (Anagraine, Metomax) 1-2 tablets (paracetamol 500mg, metoclopramide 5mg) at first signs of migraine, repeat every 4hrs if required
Drug Name Ibuprofen
Drug Class Analgesic; Antipyretic; Anti-Inflammatory; Antiplatelet (non-selective)
Mode Of Action
NSAIDs inhibit synthesis of prostaglandins by inhibiting cyclo-oxygenase (COX). COX is present in 2 forms, COX-1 and COX-2. Inhibition of COX-1 is associated with impaired gastric cytoprotection and anti-platelet effects. Inhibition of COX-2 is associated with anti-inflammatry and analgesic action. Reduction in GFR and renal blood flow is associated with both COX-1 and COX-2 inhibition
Indications
Rheumatoid arthritis, inc. juvenile RA
Osteoarthrtis
Other inflammatory arthropathies, inc. ankylosing spondyitis, psoriatic arthriti, Reiter’s Sydnrome
Pain, esp. due to inflammation and tissue injury (eg. period pain, metastatic bone pain, renal colic, headache, migraine, postoperative pain)
Fever
Precautions
Contraindicated in:
- Allergic reaction to NSAIDs
- Asthma – NSAIDs may increase risk of bronchospasm
- Coagulation Disorders – nonselective NSAIDs increase risk of bleeding (antiplatelet effect), while selective NSAIDs (and ?diclofenac) increase the risk of thrombosis
- Heart failure and hypertension – NSAIDs may ecacerbate sodium and fluid retention by reducing GFR and renal blood flow
- Active Peptic Ulcer Disease or GI Bleeding
- Renal Impairment – increased risk of NSAID-induced impairment
Adverse Effects
Common
Nausea
Dyspepsia
GI Ulceration or bleeding
Raised liver enzymes
Diarrhoea
Headache
Dizziness
Salt and fluid retention
Hypertension
Infrequent
Oesophageal ulceration, rectal irritation, heart failure, hyperkalaemia, renal impairment, confusion, bronchospasm, rash
Rare
Blood dyscrasias, interstitial nephritis, cystitis, nephrotic syndrome, acute renal failure, papillary necrosis, photosensitivity, epidermal necrolysis, hepatitis, aseptic meningitis, blurred vision, tinnitus, hypersensitivity
Dosage
Adult 200-400mg 3-4 times daily (Max 2400mg daily) (Nurofen is 200mg tablet)
Ibuprofen and Codeine Combination 1-2 tablets (ibuprofen 200mg, codeine 12.8mg) every 4 hrs if needed (max 6 tablets) (Nurofen Plus)
Drug Name Morphine
Drug Class Analgesic
Mode Of Action
Opioid analgesics mimic endogenous opioids by activating opioid receptors in the central and peripheral nervous systems to produce analgesia, respiratory depression, sedation and constipation. It predominantly acts as an agonist on -opioid receptors which are in high densities in the μamygdala, hypothalamus, thalamus, caudate nucleus, putamen. They reduce transmission of the pain impulse by acting pre- and post-synaptically in the spinal cord and by modulating the descending inhibitory pathways from the brain. Cough suppression occurs in the medullary centre of the brain.
Indications
Acute or chronic pain
Opioid adjunct during general anaesthesia
Precautions
Contraindicated in:
- Comatosed patients
- Epilepsy or a recognised risk for seizure (inc. head injury, metabolic disorders, alcohol and drug withdrawal, CNS infections) – increases risk of seizure
- Raised intracranial pressure – respiratory depression due to opioids may be poorly tlerated and may further increase intracranial pressure (avoid if possible)
- Biliary Colic – opioids may cause spasm of sphincter of Oddi
- Renal impairment – risk of accumulation of active/toxic metabolites
Adverse Effects – Adverse effects may limit achievement of adequate pain control, the options then inc. controlling symptoms, reducing opioid dose and ?adding adjuvant analgesic, switching to an alternate opioid
Common
Nausea and vomiing – may occur initially, an antiemetic may be given prophylactically
Dyspepsia
Drowsiness
Dizziness
Headache
Orthostatic hypotension
Itch
Dry mouth
Miosis
Urinary retention
Constipation – tolerance develops slowly, attention to fluid intake, diet and mobility plus regular laxative use is essential when chronic opioid treatment is started
Infrequent
Dose-related respiratory depression – judged by degree of sedation, respiratory rate reduction is late and an unreliable marker
Bronchospasm, confusion, hallucinations, delirium, agitation, mood changes, tremor, visual disturbances, urticaria, hypothermia, brady or tachycardia, hypertension, ureteric or biliary spasm, muscle rigidity, myoclonus, flushing due to histamine release
Rare
SIADH, anaphylaxis, seizure
Dosage
Adult
IV Initially 0.5-2mg repeated every 3-5min
SC/IM 7.5-12.5mg (20-39yo), 5-10mg (40-59yo), 2.5-7.5mg (60-69yo), 2.5-5mg (70-85yo), 2-3mg (>85yo) every 2 hrs as required
(Seredol (10, 20mg tab), Anamorph (30mg tab), MS Contin (5,10,15,30,60,100,200mg tab))
Drug Name Codeine
Drug Class Analgesic
Mode Of Action
Codeine is a pro-drug, it is metabolised in vivo to the primary active compounds morphine and codeine-6-glucuronide. Because it needs to be metabolised to an active form there is a ceiling effect around 400-450mg, making it less addictive.
Opioid analgesics mimic endogenous opioids by activating opioid receptors in the central and peripheral nervous systems to produce analgesia, respiratory depression, sedation and constipation. They reduce transmission of the pain impulse by acting pre- and post-synaptically in the spinal cord and by modulating the descending inhibitory pathways from the brain. Cough suppression occurs in the medullary centre of the brain.
Indications
Mild to moderate acute or chronic pain
Cough suppression
Diarrhoea
Precautions
Contraindicated in:
- Comatosed patients
- Epilepsy or a recognised risk for seizure (inc. head injury, metabolic disorders, alcohol and drug withdrawal, CNS infections) – increases risk of seizure
- Raised intracranial pressure – respiratory depression due to opioids may be poorly tlerated and may further increase intracranial pressure (avoid if possible)
- Biliary Colic – opioids may cause spasm of sphincter of Oddi
- Renal impairment – risk of accumulation of active/toxic metabolites
Adverse Effects – Adverse effects may limit achievement of adequate pain control, the options then inc. controlling symptoms, reducing opioid dose and ?adding adjuvant analgesic, switching to an alternate opioid
Common
Nausea and vomiing – may occur initially, an antiemetic may be given prophylactically
Dyspepsia
Drowsiness
Dizziness
Headache
Orthostatic hypotension
Itch
Dry mouth
Miosis
Urinary retention
Constipation – tolerance develops slowly, attention to fluid intake, diet and mobility plus regular laxative use is essential when chronic opioid treatment is started
Infrequent
Dose-related respiratory depression – judged by degree of sedation, respiratory rate reduction is late and an unreliable marker
Bronchospasm, confusion, hallucinations, delirium, agitation, mood changes, tremor, visual disturbances, urticaria, hypothermia, brady or tachycardia, hypertension, ureteric or biliary spasm, muscle rigidity, myoclonus, flushing due to histamine release
Rare
SIADH, anaphylaxis, seizure
Dosage
Adult 30-60mg every 4 hours (Oral/SC/IM), max 240mg per 24hrs (Codeine phosphate - 30mg tab, 50mg/mL inj)
Drug Name Fentanyl
Drug Class Analgesic
Mode Of Action
Opioid analgesics mimic endogenous opioids by activating opioid receptors in the central and peripheral nervous systems to produce analgesia, respiratory depression, sedation and constipation. They reduce transmission of the pain impulse by acting pre- and post-synaptically in the spinal cord and by modulating the descending inhibitory pathways from the brain. Cough suppression occurs in the medullary centre of the brain.
Indications
Acute pain
Opioid adjunct during general anaesthesia
Chronic pain (for patients intolerant of morphine) – first choice for use in cancer patients
Breakthrough pain
Precautions
Contraindicated in:
- Bradyarrhythmias may be exacerbated
- Comatosed patients
- Epilepsy or a recognised risk for seizure (inc. head injury, metabolic disorders, alcohol and drug withdrawal, CNS infections) – increases risk of seizure
- Raised intracranial pressure – respiratory depression due to opioids may be poorly tlerated and may further increase intracranial pressure (avoid if possible)
- Biliary Colic – opioids may cause spasm of sphincter of Oddi
- Renal impairment – risk of accumulation of active/toxic metabolites
Adverse Effects – Adverse effects may limit achievement of adequate pain control, the options then inc. controlling symptoms, reducing opioid dose and ?adding adjuvant analgesic, switching to an alternate opioid
Common
Nausea and vomiing – may occur initially, an antiemetic may be given prophylactically
Dyspepsia
Drowsiness
Dizziness
Headache
Orthostatic hypotension
Itch
Dry mouth
Miosis
Urinary retention
Constipation – tolerance develops slowly, attention to fluid intake, diet and mobility plus regular laxative use is essential when chronic opioid treatment is started
Infrequent
Dose-related respiratory depression – judged by degree of sedation, respiratory rate reduction is late and an unreliable marker
Bronchospasm, confusion, hallucinations, delirium, agitation, mood changes, tremor, visual disturbances, urticaria, hypothermia, brady or tachycardia, hypertension, ureteric or biliary spasm, muscle rigidity, myoclonus, flushing due to histamine release
Rare
SIADH, anaphylaxis, seizure
Dosage
Adult
Spontaneous Ventilation UV 50-100micrograms, then 25-50micrograms s required
Assisted Ventilation IV 50micrograms-3.5mg, then 50-200micrograms or more as required
Usually given in combination with a benzodiazepine such as midazolam
There are also transdermal patches which release fentanyl into body fats which slowly release into the blood stream over 48-72hrs
ANAESTHETICS
General Anaestheisa involves:
Preoperative assessment with or without premedication, to ensure that the process of anaesthesia is as safe as possible
Induction, to render the patient unconscious and unreactive to surgical stimuli (using IV or inhaled drugs)
Maintenance, to keep the patient anaesthetised for as long as the operation lasts (using IV and/or inhaled drugs with muscle relaxants and analgesics as necessary)
Reversal, if non-depolarising muscle relaxants are used, reversal with neostigmine (and an anticholinergic to prevent undesirable muscarinic effects, esp. bradycardia) is usually required when the operation is completed
Recovery, which begins when the anaesthetic is stopped and lasts until the patient is fully conscious, has stable cardiovascular status, is able to maintain own airway and is comfortable
IV General Anaesthetics
In appropriate doses IV general anaesthetic drugs produce rapid, reversible loss of consciousness and insensibility to surgical stimuli
Types of IV General Anaesthetis
Ketamine
Propofol
Midazolam
Thiopentone
Inhaled Anaesthetics
Their anaesthetic effect is directly proportional to the partial pressure of the drug in the brain, factors which shorten the induction time inc.
High inspired concentration
Increased alveolar ventilation
Reduced cardiac output
Low blood:gas solubility
Increased alveolar-to-capillary partial pressure difference
Potency is measured by minimum alveolar concentration (MAC) to which it is inverely related - MAC is the alveolar concentration that prevents movement in response to a skin incision in 50% of patients, it decreases as age increases
Types of Inhaled Anaesthetics
Volatile Anaesthetics (liquid at room temperature)
Desflurane
Isoflurane
Methoxyflurane
Sevoflurane
Other Inhaled Anaesthetics
Nitrous Oxide
Nuromuscular Blockers
Types of Neuromuscular Blockers
Neuromuscular blocking drugs produce skeletal (inc. respiratory) muscle relaxation which is used during general anaesthesia.
Non-Depolarising Neuromuscular Blockers
Atracurium
Cisatracurium
Mivacurium
Pancuronium
Rocuronium
Vecuronium
Depolarising Neuromuscular Blockers
Suxamethonium
Other Anaesthetic Agents
Alpha2 and Imidazoline Agonists
Clonidine
Dexmedetomide
Opioids (anaesthesia)
Alfentanil
Remifentanil
Anticholinergics (anaesthesia)
Glycopyrrolate
Drugs for Local Anaesthesia
Amethocaine (skin)
Bupivacaine
Cocaine
Levobupivacaine
Lidnocaine
Prilocaine
Procaine
Drug Name Ketamine
Drug Class Anaesthetic (General)
Mode Of Action
Antagonises NMDA receptors, also interacts with muscarinic receptors, descending monoaminergic pain pathways, voltage-sensitive calcium channels and opioid receptors in the brain and spinal cord
Is a potent analgesic at subanaesthetic concentrations. It can cause cardiovascular and respiratory stimulation at recommended doses, it maintains pharyngeal and laryngeal reflexes compared with other IV anaesthetic agents.
Indications
Induction and maintenance of anaesthesia
Pain relief
Precautions
Contraindicated in:
- Conditions which may be worsened by an increase in BP and/or heart rate, inc. poorly controlled hypertension, stroke, intracerebral haemorrhage, angina, recent MI, stenotic valvular heart disease, tachyarrhythmias, chronic heart failure – ketamine increases BP and heart rate
- Psychiatric disorders – hallucinations, irrational behaviour may occur
- Raised intracranial or intraocular pressure – may be further raised
- Addisions Disease, severe anaemia, myxoedema – hypnotic effect may be prolonged or potentiated
- Debilitated patients – more sensitive to adverse and anaesthetic effects
- IV anaesthetics may worsen symptoms of cardiovascular compromise (hypotension, hypovolaemia)
Adverse Effects
Common
Raised BP and HR
Increased muscle tone (sometimes tonic-clonic and resembling seizures)
Lacrimation
Hypersalivation
Raised intracranial pressure
Raised intraocular pressure
Emergence reactions – inc. vivid dreams, restlessness, confusion, hallucinations and irrational behaviour
Infrequent
Diplopia, nystagmus, postoperative nausea and vomiting, hypotension and bradycardia, pain on injection, erythema, morbilliform rash
Rare
Apnoea, laryngospasm, arrhythmias, anaphylaxis
Dosage
Adult
IV 1-4.5mg/kg (usually 2mg/kg over 60s provides anaesthesia within 30s lasting for 5-10min)
IM 6.5-13mg/kg (usually 10mg/kg provides anaesthesia within 3-4min lasting 12-25min)
Drug Name Propofol
Drug Class Anaesthetic (General)
Mode Of Action (uncertain)
Its main CNS depressant action is thought to be via the GABA receptor at a site different to that of barbiturates and benzodiazepines. May also shorten channel opening times at nicotinic acetylcholine receptors and sodium channels in the cerebral cortex.
Is most effective at suppressing pharyngeal and laryngeal reflexes allowing rapid control of the airway, inc. insertion of laryngeal mask and endotracheal intubation. Has some antiemetic effect, causing less post-operative nausea and vomiting when used alone.
Indications
Induction and maintenance of anaesthesia
Conscious sedation (midazolam, propofol)
Sedation during ventilation (midazolam, propofol)
Precautions
Contraindicated in:
- Addisions Disease, severe anaemia, myxoedema – hypnotic effect may be prolonged or potentiated
- Debilitated patients – more sensitive to adverse and anaesthetic effects
- IV anaesthetics may worsen symptoms of cardiovascular compromise (hypotension, hypovolaemia)
- Severe respiratory compromise – further respiratory depression occurs
Adverse Effects
Common
Pain on injection
Bradycardia
Hypotension
Apnoea
Flushed skin or rash
Cough
Excitation at induction (involuntary movements inc. twitches, tremors, hypertonus and hiccup)
Infrequent
Arrhythmias, thrombosis, phlebitis at injection site
Rare
Anaphylactic reactions, seizure, fever, pancreatitis
Dosage
Adult (1% preparation – 10mg/mL available as 20, 50, 100mL preparations)
IV 2-2.5mg/kg (9-55yo), 1-1.5mg/kg (>55yo or debilitated)
Drug Name Midazolam
Drug Class Anaesthetic (General); Benzodiazepine
Mode Of Action
Potentiates the inhibitory effects of GABA throughout the CNS, resulting in anxiolytic, sedative, hypnotic, anterograde amnesic, muscle relaxant and antiepileptic effects
Is the least effective IV agent for induction of anaesthesia, but is anterograde amnesic effect may be useful.
Indications
Induction and maintenance of anaesthesia
Conscious sedation (midazolam, propofol)
Sedation during ventilation (midazolam, propofol)
Premedication
Status epilepticus
Precautions
Contraindicated in:
- Addisions Disease, severe anaemia, myxoedema – hypnotic effect may be prolonged or potentiated
- Debilitated patients – more sensitive to adverse and anaesthetic effects
- IV anaesthetics may worsen symptoms of cardiovascular compromise (hypotension, hypovolaemia)
- Respiratory disease, sleep apnoea – compromised respiratory drive may result in hypoventilation and hypoxaemia
Adverse Effects
Common
Hypotension
Hiccup
Cough
Infrequent
Pain on injection, erythema, rash, bronchospasm, nasuea, vomiting, headache, confusion, restlessness
Rare
Arrhythmias, cardiorespiratory arrest, anaphylactic reactions
Dosage
Adult (1mg/mL 5mL; 5mg/mL 1, 3, 10mL preparations)
Conscious Sedation IV 2-2.5mg, give further 1mg as needed
Drug Name Thiopentone
Drug Class Anaesthetic (General); Barbiturate
Mode Of Action
Potentiates action of the inhibitory neurotransmitter GABA at multiple sites in the CNS resulting in sedative, hypnotic, anaesthetic and anticonvulsant effects. It also depressesthe actions of excitatory neurotransmitters in the CNS. Redistribution of cerebral blood flow to injured areas may also be involved in its neuroprotective effect.
Produces the most rapid onset of anaesthesia, but recovery is slower than with propofol.
Indications
Induction and maintenance of anaesthesia
Short surgical procedures, sole agent
Seizures, short term control
Cerebral protection
Raised intracranial pressure
Precautions
Contraindicated in:
- Addisions Disease, severe anaemia, myxoedema – hypnotic effect may be prolonged or potentiated
- Debilitated patients – more sensitive to adverse and anaesthetic effects
- IV anaesthetics may worsen symptoms of cardiovascular compromise (hypotension, hypovolaemia)
- Allergy to barbiturates
- Porphyria
- Asthma – bronchospasm may occur
- Severe respiratory compromise – further respiratory depression occurs
Adverse Effects
Common
Transient erythema noted as lushing
Hypotension
Respiratory and myocardial depression
Prolonged somnolence with repeated doses
Infrequent
Laryngospasm, pain at injection site
Rare
Anaphylaxis, bronchospasm
Dosage
Adult (administered as a 2.5% solution (25mg/mL))
IV Bolus 3-5mg/kg according to response; additional injections of 25-50mg when needed
Drug Name Nitrous Oxide
Drug Class Anaesthetic (Inhaled)
Mode Of Action
Enhance the inhibitory ion channel activity and inhibit excitatory activity in the brain to induce hypnosis and amnesia, and in the spinal cord to cause immobility in response to painful stimuli
Indications
Induction and maintenance of general anaesthesia
Analgesia (in subanaesthetic concentrations)
Precautions
Contraindicated in:
- Myasthenia gravis – muscle weakness may increase
- Susceptibility to malignant hypethermia
- Vitamin B12 deficiency – increased risk of neurological dysfunction, inc. subacute combined degeneration of the spinal cord with prolonged exposure
Adverse Effects
Common
Shivering (independent of temperature)
Nausea and vomiting
Infrequent
Arrhythmias
Rare
Megaloblastic anaemia, leucopeia, agranulocytosis, neuropathy, myeloneuropathy (with prolonged or repeated use)
Dosage
Adult 70% with 30% oxygen (analgesia 25-50% with oxygen)
Drug Name Vecuronium
Drug Class Anaesthetic (Neuromuscular Blocker)
Mode Of Action
Indications
Precautions
Contraindicated in:
Adverse Effects
Common
Rare
Dosage
Adult
Drug Name Suxamethonium
Drug Class Anaesthetic (Neuromuscular Blocker)
Mode Of Action
Indications
Precautions
Contraindicated in:
Adverse Effects
Common
Rare
Dosage
Adult
Drug Name Clonidine
Drug Class Anaesthetic
Mode Of Action
Indications
Precautions
Contraindicated in:
Adverse Effects
Common
Rare
Dosage
Adult
Drug Name Cocaine
Drug Class Local Anaesthetic
Mode Of Action
Indications
Precautions
Contraindicated in:
Adverse Effects
Common
Rare
Dosage
Adult
Drug Name Lidnocaine
Drug Class Local Anaesthetic
Mode Of Action
Indications
Precautions
Contraindicated in:
Adverse Effects
Common
Rare
Dosage
Adult
CARDIOVASCULAR DRUGS
Drugs for Heart Failure
Aldosterone Antagonists
Eplerenone
Spironolactone
Loop Diuretics
Bumetanide
Ethacryic Acid
Frusemide
Sympathomimetics
Adrenaline
Dobutamine
Dopamine
Noradrenaline
Drugs for Angina and Acute Coronary Syndromes
Nitrates
Glyceryl Trinitrate
Isosorbide Dinitrate
Isosorbide Mononitrate
Other Antianginal Drugs
Ivabradine
Nicorandil
Perhexiline
Antihypertensives
Thiazide and Diuretics
Chlorthalidone
Hydrochlorothiazide
Indapamide
Potassium-Sparing Diuretics
Amiloride
Beta-Blockers
Atenolol
Bisoprolol
Carvedilol
Labetalol
Metoprolol
Oxprenolol
Pindolol
Propranolol
ACE Inhibitors
Catopril
Enalapril
Fosinopril
Lisinopril
Perindopril
Quinapril
Ramipril
Trandolapril
Calcium-Channel Blockers
Amlodipine
Diltiazem
Felodipine
Lercanidipine
Nifedipine
Nimodipine
Verapamil
Vasodilators
Diazoxide
Hydralazine
Minoxidil
Sodium Nitroprusside
Centrally Acting Hypertensives
Clonidine (see Anaesthetic Agents)
Methyldopa
Moxonidine
Non-Selective Alpha-Blockers
Phenoxybenzamine
Phentolamine
Selective Alpha-Blockers
Prazosin
TerazosinAntiarrhythmics
Adenosine
Amiodarone
Atropine
Digoxin
Disopyramide
Esmolol
Flecainide
Soprenaline
Lignocaine (see Anaesthetic Agents)
Mexiletine
Sotalol
Statins (Drugs fo Dyslipidaemia)
Atorvastatin
Fluvastatin
Pravastatin
Rosuvastatin
Simvastatin
Drug Name
Drug Class Anaesthetic
Mode Of Action
Indications
Precautions
Contraindicated in:
Adverse Effects
Common
Rare
Dosage
Adult
BLOOD AND ELECTROLYTES
Anticoagulants
Heparins
Dalteparin (LMWH)
Danaparoid
Enoxaparin (LMWH)
Heparin
Vitamin K Antagonists
Phenindione
Warfarin
Antiplatelet Drugs – antiplatelet drugs inhibit platelet aggregation, they are used in the management of arterial thrombosis (clots initially made of platelets), they are not used in management of VTE (fibrin clots)
Glycoprotein IIb/IIIa Inhibitors
Abciximab
Eptifibatide
Tirofiban
Other Antiplatelet Drugs
Aspirin
Clopidogrel
Dipyridamole
Ticlopidine
Thrombolytics
Alteplase
Reteplase
Streptokinase
Tenecteplase
Urokinase
Other Drugs Affecting Haemostasis
Vitamin K
Tranexamic Acid
Drugs For Anaemia
Folic Acid
Iron
Vitamin B12
Drug Name Heparin (standard or unfractionated), Dalteparin and Enoxaparin are LMWHs
Drug Class Anticoagulants
Mode Of Action
Inactivate clotting factors IIa (thrombin) and Xa by binding to antithrombin III, LMWHs have a much greater effect on Factor Xa than on thrombin.
Indications
Prevention of VTE and other thromboses in surgical and high risk medical patients
Treatment of VTE
Treatment of acute coronary syndromes
Treatment of peripheral arterial occlusion
Treatment of DIC
Precautions
Contraindicated in:
- Those with a risk of bleeding inc. thrombocytopenia, bleeding disorders (haemophilia), peptic ulcer, recent cerebral haemorrhage, severe uncontrolled hypertension, bacterial endocarditis, major trauma or recent surgery
- Renal impairment (use heparin rather than LMWH)
(safe to use in pregnancy and breastfeeding)
Adverse Effects
Common
Bleeding
Bruising and pain at injection site
Hyperkalaemia
Mild reversible thrombocytopenia
Infrequent
Transient elevation in liver aminotransferases, severe thrombocytopenia
Rare
Skin necrosis (at injection site), osteoporosis and alopecia with long term use, allergic reactions including urticaria
Dosage
Adult - Prevention (Heparin or Dalteparin)
SC 5000 units 2-3 times daily fr 7-10 days or until mobilised (medical high risk patients)
Drug Name Warfarin (Coumadin, Marevan)
Drug Class Anticoagulants, Vitamin K Antagonists
Mode Of Action
Inhibits synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) and the antithrombotic factors protein C and protein S
Indications
Prevention and treatment of VTE (DVT, PE)
Prevention of thromboembolism in patients with prosthetic heart valves
Primary prevention of stroke in patients with AF associated with mitral valvulopathy and other risk factors
Secondary prevention of stroke in patients with AF
Prevention of thromboembolism before and after cardioversion for AF
Prevention of stroke in patients with previous MI and increased embolic risk
Precautions
Contraindicated in:
- Patients with high risk of bleeding – bleeding disorders, previous GI bleeding, haemorrhagic retinopathy, intracerebral aneurysm or haemorrhage, severe hypertension, bacterial endocarditis, frequent falls
- Caution in patients with renal and/or hepatic impairment
Surgery – it is safe to continue warfarin in people with high risk of thromboembolism where there is a low risk of significant bleeding, otherwise stop warfarin 4-5days before elective surgery to allow the INR to return to normal (give IV heparin or SC LMWH)
Adverse Effects
Common
Bleeding
Rare
Skin necrosis, purple discolouration of toes, allergic reactions, alopecia, fever, rash, nausea, vomiting, diarrhoea, hepatic dysfunction
Dosage
Adult usually 5mg daily for 2 days then adjust according to INR, usual maintenance dose 1-10mg daily
Drug Name Aspirin (acetylsalicyclic acid) (Aspirin, Cardiprin, Cartia, Aspro clear, Solprin, Astrix)
Drug Class Antiplatelet Agent
Mode Of Action
Inhibits platelet aggregation by irreversibly inhibiting cyclo-oxygenase, reducing the synthesis of thromboxane A2 (an inducer of platelet aggregation) for the life of the platelet
Indications
Acute MI
Unstable angina
Primary and secondary prevention of stroke and acute MI in patients with risk factors
Secondary prevention in ischaemic heart disease (angina, MI, after CABG)
Prevention of thromboembolism in non-rheumatic AF in low risk patients
Relief of pain, inflammation and fever
Precautions
Contraindicated in:
- Those with a risk of bleeding inc. thrombocytopenia, bleeding disorders (haemophilia), peptic ulcer, recent cerebral haemorrhage, severe uncontrolled hypertension, bacterial endocarditis, major trauma or recent surgery
- Renal and/or hepatic impairment
Adverse Effects
Common
GI irritation
Asymptomatic blood loss
Increased bleeding time
Infrequent
Stevens-Johnson syndrome, toxic epidermal necrolysis, iron deficiency anaemia, GI haemorrhage
Rare
Intracranial haemorrhage, GI ulcer
Dosage
Adult
75-150mg daily is effective for long term use
150-300mg daily may be required in acute conditions
Drug Name Clopidogrel (Iscover, Plavix)
Drug Class Antiplatelet Drug
Mode Of Action
Inhibits bindig of adenosine diphosphate (ADP) to its platelet receptor, and the subsequent ADP-mediated activation of the glycoprotein IIb/IIIa complex, thereby inhibiting platelet aggregation
Indications
Prevention of vascaular ischaemic events in patients with symptomatic atherosclerosis (recent ischaemic stroke, recent MI, peripheral arterial disease)
Non-ST segment elevation acute coronary syndrome (with aspirin)
Adjuvant to reperfusion therapy for STEMI (with aspirin), unless acute coronary artery bypass grafting is likely
Precautions
Contraindicated in:
- Those with a risk of bleeding inc. thrombocytopenia, bleeding disorders (haemophilia), peptic ulcer, recent cerebral haemorrhage, severe uncontrolled hypertension, bacterial endocarditis, major trauma or recent surgery
- Renal and hepatic impairment
Adverse Effects
Common
Bleeding
Diarrhoea
Rash
Infrequent
Intracranial bleeding, GI ulcer
Rare
Thrombotic thrombocytopenic purpur, aplatic anamia, thrombocytopenia, neutropenia, allergy including angioedema and Steven-Johnson syndrome
Dosage
Adult
75mg daily (preventive dose)
Drug Name Streptokinase (Streptase)
Drug Class Thrombolytics
Mode Of Action
Convert plasminogen to plasmin, which catalyses the breakdown of fibrin
Indications
Acute STEMI
Acute massive VTE in patients who are haemodynamically unstable
Peripheral arterial thromboembolism
Thrombosed IV cannulae, central venous catheters and haemodialysis shunts
Acute ischaemic stroke within 3 hours of onset of symptoms
Precautions
Contraindicated in:
- Those with a risk of bleeding inc. thrombocytopenia, bleeding disorders (haemophilia), peptic ulcer, recent cerebral haemorrhage, severe uncontrolled hypertension, bacterial endocarditis, major trauma or recent surgery
- Hepatic impairment
Adverse Effects
Common
Hypotension
Bleeding (inc. at injection sites)
Intracerebral bleeding
Internal bleeding
Infrequent
Allergic reactions including fever, chills, rash, nausea, headache, bronchospasm, anaphylaxis, vasculitis, nephritis, hypotension
Rare
Cholesterol embolism
Dosage
Adult - Prevention (Heparin or Dalteparin)
Acute STEMI – 1500000 units over 30-60min (IV infusion)
DVT – 250000 units over 30min, then 100000 units/hr for 24-72 hours (IV infusion)
Drug Name Iron
Drug Class Drugs For Anaemia
Mode Of Action
Essential element required for the formation of haemoglobin and myoglobin
Indications
Prevention and treatment of iron deficiency anaemia
Treatment of iron deficiency anaemia in people on haemodialysis receiving epoetin
Precautions
Contraindicated in:
- Haemochromatosis
- Anaemia not due to iron deficiency
(safe to use in pregnancy and breastfeeding)
Adverse Effects
Common
Abdominal pain
Nausea
Vomiting
Constipation
Diarrhoea
Black discolouration of faeces
Dosage
Adult - (1mg of elemental iron is equivalent to 3mg ferrous fumarate, 3mg ferrous sulfate)
Treatment of iron deficiency – 100-200mg daily (orally)